Clinical Trial

Fluorometholone Study

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The investigators seek to determine whether adjunctive topical fluorometholone (FML) improves best-corrected visual acuity (BCVA) at 3 months in patients with bacterial corneal ulcers compared with standard topical antibiotic therapy alone.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-12-27; most recent amendment 2026-06-07.
Trial Details
NCT Number NCT07308938
Lead Sponsor Vishal Jhanji
Collaborators: University of Pittsburgh Medical Center
Conditions Keratitis Bacterial, Corneal Ulcer (Diagnosis)
Enrollment 174 participants
Start Date 2026-10-31
Primary Completion 2029-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-10